The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens
- PMID: 2960766
- DOI: 10.1002/jlb.42.6.632
The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens
Abstract
The present study investigates the mechanisms of the recognition of tumor antigens by L3T4+ helper T cells responsible for the generation of Lyt-2+ cytotoxic T lymphocytes (CTL) against a major histocompatibility complex (MHC) Class II (Ia) antigen-negative syngeneic X5563 plasmacytoma. Treatment of X5563-immunized spleen cells with anti-L3T4 antibody plus complement (C) diminished the generation of Lyt-2+ anti-X5563 CTL. Since the contribution of L3T4+ cells was completely replaced by the addition of exogenous lymphokines, it was demonstrated that L3T4+ cells functioned as helper T cells assisting the generation of anti-X5563 CTL responses. Elimination of Ia-positive accessory cells (AC) from X5563-immunized spleen cells resulted in the abrogation of CTL generation, whereas the addition of exogenous lymphokines to AC-depleted X5563 immunized spleen cells restored the CTL response. The addition of anti-self Ia antibody to the culture also eliminated CTL responses. These observations demonstrated the requirement of Ia-positive AC for and the involvement of self Ia antigens in the activation of helper T cells. Moreover, use of tumor cells pretreated with paraformaldehyde to cultures of X5563-immunized spleen cells or adding back of AC pretreated with chloroquine to cultures of AC-depleted immune spleen cells failed to generate CTL responses. Finally, the addition of exogenous lymphokines to the above cultures resulted in appreciable restoration of CTL responses. Taken collectively, these results indicate that L3T4+ helper T cells are activated with tumor antigens processed and presented by Ia-positive AC.
Similar articles
-
Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.J Immunol. 1986 Jun 1;136(11):4303-10. J Immunol. 1986. PMID: 2422280
-
Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.J Immunol. 1986 Apr 1;136(7):2715-9. J Immunol. 1986. PMID: 3005417
-
The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.J Immunol. 1984 Sep;133(3):1671-6. J Immunol. 1984. PMID: 6205091
-
A monoclonal antibody that blocks class II histocompatibility-related immune interactions.Hum Immunol. 1984 May;10(1):23-40. doi: 10.1016/0198-8859(84)90083-1. Hum Immunol. 1984. PMID: 6233239 Review.
-
Cell surface structures involved in T cell activation.Immunol Rev. 1984 Oct;81:65-94. doi: 10.1111/j.1600-065x.1984.tb01105.x. Immunol Rev. 1984. PMID: 6239820 Review.
Cited by
-
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8633-8. doi: 10.1073/pnas.96.15.8633. Proc Natl Acad Sci U S A. 1999. PMID: 10411927 Free PMC article.
-
Tumor-specific T cell lines: capacity to proliferate and produce interleukin 2 in response to various forms of tumor antigens.Jpn J Cancer Res. 1992 Feb;83(2):184-93. doi: 10.1111/j.1349-7006.1992.tb00085.x. Jpn J Cancer Res. 1992. PMID: 1372887 Free PMC article.
-
Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells.Cancer Immunol Immunother. 1992;35(1):1-6. doi: 10.1007/BF01741047. Cancer Immunol Immunother. 1992. PMID: 1611618 Free PMC article.
-
Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burden.J Cancer Res Clin Oncol. 1994;120(5):279-85. doi: 10.1007/BF01236384. J Cancer Res Clin Oncol. 1994. PMID: 7907334 Free PMC article.
-
Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset.Jpn J Cancer Res. 1988 Jan;79(1):99-108. doi: 10.1111/j.1349-7006.1988.tb00016.x. Jpn J Cancer Res. 1988. PMID: 3128511 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials